These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 33128580)

  • 1. HMGB1: an important regulator of myeloid differentiation and acute myeloid leukemia as well as a promising therapeutic target.
    Liu L; Zhang J; Zhang X; Cheng P; Liu L; Huang Q; Liu H; Ren S; Wei P; Wang C; Dou C; Chen L; Liu X; Zhang H; Chen M
    J Mol Med (Berl); 2021 Jan; 99(1):107-118. PubMed ID: 33128580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic therapy with chidamide alone or combined with 5‑azacitidine exerts antitumour effects on acute myeloid leukaemia cells
    Li Z; Zhang J; Zhou M; Li JL; Qiu QC; Fu JH; Xue SL; Qiu HY
    Oncol Rep; 2022 Apr; 47(4):. PubMed ID: 35103292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cooperative effect of chidamide and chemotherapeutic drugs induce apoptosis by DNA damage accumulation and repair defects in acute myeloid leukemia stem and progenitor cells.
    Li Y; Wang Y; Zhou Y; Li J; Chen K; Zhang L; Deng M; Deng S; Li P; Xu B
    Clin Epigenetics; 2017; 9():83. PubMed ID: 28814980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of EZH2 by chidamide exerts antileukemia activity and increases chemosensitivity through Smo/Gli-1 pathway in acute myeloid leukemia.
    Jiang X; Jiang L; Cheng J; Chen F; Ni J; Yin C; Wang Q; Wang Z; Fang D; Yi Z; Yu G; Zhong Q; Carter BZ; Meng F
    J Transl Med; 2021 Mar; 19(1):117. PubMed ID: 33743723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A New Strategy to Target Acute Myeloid Leukemia Stem and Progenitor Cells Using Chidamide, a Histone Deacetylase Inhibitor.
    Li Y; Chen K; Zhou Y; Xiao Y; Deng M; Jiang Z; Ye W; Wang X; Wei X; Li J; Liang J; Zheng Z; Yao Y; Wang W; Li P; Xu B
    Curr Cancer Drug Targets; 2015; 15(6):493-503. PubMed ID: 26282548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apicidin confers promising therapeutic effect on acute myeloid leukemia cells via increasing QPCT expression.
    Liu L; Liu H; Liu L; Huang Q; Yang C; Cheng P; Ren S; Zhang J; Yu M; Ma X; Song W; Chen L; Zhang H; Chen M; Zhang X
    Cancer Biol Ther; 2023 Dec; 24(1):2228497. PubMed ID: 37381175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-inhibition of HDAC and MLL-menin interaction targets MLL-rearranged acute myeloid leukemia cells via disruption of DNA damage checkpoint and DNA repair.
    Ye J; Zha J; Shi Y; Li Y; Yuan D; Chen Q; Lin F; Fang Z; Yu Y; Dai Y; Xu B
    Clin Epigenetics; 2019 Oct; 11(1):137. PubMed ID: 31590682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-451 Promotes Cell Apoptosis and Inhibits Autophagy in Pediatric Acute Myeloid Leukemia by Targeting HMGB1.
    Zhang Y; Chu X; Wei Q
    J Environ Pathol Toxicol Oncol; 2021; 40(2):45-53. PubMed ID: 33822516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased PRAME-specific CTL killing of acute myeloid leukemia cells by either a novel histone deacetylase inhibitor chidamide alone or combined treatment with decitabine.
    Yao Y; Zhou J; Wang L; Gao X; Ning Q; Jiang M; Wang J; Wang L; Yu L
    PLoS One; 2013; 8(8):e70522. PubMed ID: 23940586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical evaluation of a regimen combining chidamide and ABT-199 in acute myeloid leukemia.
    Chen K; Yang Q; Zha J; Deng M; Zhou Y; Fu G; Bi S; Feng L; Xu-Monette ZY; Chen XL; Fu G; Dai Y; Young KH; Xu B
    Cell Death Dis; 2020 Sep; 11(9):778. PubMed ID: 32948748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-34a Promotes Apoptosis and Inhibits Autophagy by Targeting HMGB1 in Acute Myeloid Leukemia Cells.
    Liu L; Ren W; Chen K
    Cell Physiol Biochem; 2017; 41(5):1981-1992. PubMed ID: 28478444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chidamide works synergistically with Dasatinib by inducing cell-cycle arrest and apoptosis in acute myeloid leukemia cells.
    Deng M; Xiao H; Peng H; Yuan H; Xiao X; Liu S
    Mol Cell Biochem; 2023 Apr; 478(4):851-860. PubMed ID: 36107284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of SALL4 Protein Enhances All-trans Retinoic Acid-induced Cellular Differentiation in Acute Myeloid Leukemia Cells.
    Liu L; Liu L; Leung LH; Cooney AJ; Chen C; Rosengart TK; Ma Y; Yang J
    J Biol Chem; 2015 Apr; 290(17):10599-609. PubMed ID: 25737450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chidamide in FLT3-ITD positive acute myeloid leukemia and the synergistic effect in combination with cytarabine.
    Li X; Yan X; Guo W; Huang X; Huang J; Yu M; Ma Z; Xu Y; Huang S; Li C; Zhou Y; Jin J
    Biomed Pharmacother; 2017 Jun; 90():699-704. PubMed ID: 28419965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corilagin induces apoptosis and inhibits autophagy of HL‑60 cells by regulating miR‑451/HMGB1 axis.
    Jia S; He D; Liang X; Cheng P; Liu J; Chen M; Wang C; Zhang H; Meng C
    Mol Med Rep; 2022 Jan; 25(1):. PubMed ID: 34850958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radotinib Induces Apoptosis of CD11b+ Cells Differentiated from Acute Myeloid Leukemia Cells.
    Heo SK; Noh EK; Yoon DJ; Jo JC; Choi Y; Koh S; Baek JH; Park JH; Min YJ; Kim H
    PLoS One; 2015; 10(6):e0129853. PubMed ID: 26065685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-181b increases drug sensitivity in acute myeloid leukemia via targeting HMGB1 and Mcl-1.
    Lu F; Zhang J; Ji M; Li P; Du Y; Wang H; Zang S; Ma D; Sun X; Ji C
    Int J Oncol; 2014 Jul; 45(1):383-92. PubMed ID: 24756163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting BMAL1 reverses drug resistance of acute myeloid leukemia cells and promotes ferroptosis through HMGB1-GPX4 signaling pathway.
    Zheng H; Wu T; Lin Z; Wang D; Zhang J; Zeng T; Liu L; Shen J; Zhao M; Li JD; Yang M
    J Cancer Res Clin Oncol; 2024 May; 150(5):231. PubMed ID: 38703241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic priming of AML blasts for all-trans retinoic acid-induced differentiation by the HDAC class-I selective inhibitor entinostat.
    Blagitko-Dorfs N; Jiang Y; Duque-Afonso J; Hiller J; Yalcin A; Greve G; Abdelkarim M; Hackanson B; Lübbert M
    PLoS One; 2013; 8(10):e75258. PubMed ID: 24116031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-aminoimidazole-4-carboxamide ribonucleoside induces differentiation in a subset of primary acute myeloid leukemia blasts.
    Dembitz V; Lalic H; Kodvanj I; Tomic B; Batinic J; Dubravcic K; Batinic D; Bedalov A; Visnjic D
    BMC Cancer; 2020 Nov; 20(1):1090. PubMed ID: 33176741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.